mRNA can encode virtually any protein, but its true potential hinges on delivering the right sequence to the right tissues at the right time. With precise targeting and selective translation, in vivo cell programming becomes possible.
This is the “kernal” of mRNA 2.0.
Our mRNA 2.0 platform uses intelligently programmed mRNA that is precisely delivered and selectively translated in target cells — enabling scalable in vivo CAR-T therapies for oncology and immunology
See how it works